ConductScience.org, home

Paper41501725

Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.

Zhang W and 9 others. Cancer Cell Int, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma. Papers, record 41501725. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41501725

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-20
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang WWei
2Xia SShunjin
3Xiao YYanming
4Liu HHongwei
5Wang CChaoqian
6Dai LLuohuan
7Chen YYinhua
8Lin XXuelei
9Liu HHongyi
10Jiang NNian

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022JJ40793Hunan Provincial Natural Science Foundation of ChinaPubMed
82403354The National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42021255Correction: Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.https://conductscience.org/library/papers/42021255

Source PubMed

Download CSV of comments and corrections

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124491301Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.J Natl Cancer Inst2014https://conductscience.org/library/papers/24491301PubMed
235077679Early human embryonic development: Blastocyst formation to gastrulation.Dev Cell2022https://conductscience.org/library/papers/35077679PubMed
328892058Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis.Nat Neurosci2017https://conductscience.org/library/papers/28892058PubMed
427713747Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation.Front Immunol2016https://conductscience.org/library/papers/27713747PubMed
538538696Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response.NPJ Precis Oncol2024https://conductscience.org/library/papers/38538696PubMed
630787268ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway.Cell Death Dis2019https://conductscience.org/library/papers/30787268PubMed
736322624ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling.Neuro Oncol2023https://conductscience.org/library/papers/36322624PubMed
835668574Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.Cancer Med2023https://conductscience.org/library/papers/35668574PubMed
937149929Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis.EBioMedicine2023https://conductscience.org/library/papers/37149929PubMed
1034594038Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response.Nat Genet2021https://conductscience.org/library/papers/34594038PubMed
1139055398Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/39055398PubMed
1234608945CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.Neuro Oncol2021https://conductscience.org/library/papers/34608945PubMed
1328407030Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.Ann Oncol2017https://conductscience.org/library/papers/28407030PubMed
1433023892The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.Cancer Discov2021https://conductscience.org/library/papers/33023892PubMed
1538322112Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy.Int J Clin Pract2024https://conductscience.org/library/papers/38322112PubMed
1637738997Primary brain tumours in adults.Lancet2023https://conductscience.org/library/papers/37738997PubMed
1734692159Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies.Natl Sci Rev2020https://conductscience.org/library/papers/34692159PubMed
1837192616The single-cell and spatial transcriptional landscape of human gastrulation and early brain development.Cell Stem Cell2023https://conductscience.org/library/papers/37192616PubMed
1938183840Glioblastoma vaccines: past, present, and opportunities.EBioMedicine2024https://conductscience.org/library/papers/38183840PubMed
2034012965The Role of Neurodevelopmental Pathways in Brain Tumors.Front Cell Dev Biol2021https://conductscience.org/library/papers/34012965PubMed

See all 49 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42021255Correction: Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.Cancer Cell Int2026https://conductscience.org/library/papers/42021255

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MEST4232PubTator's text mininghttps://conductscience.org/library/genes/4232

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41501725

GET https://conductscience.org/api/papers/v1/41501725/references?page=2